Jobs

Currently 567 R&D/BioTech jobs


Candidates Login

Forgotten details?

CV Database

Let the jobs come to you!


Company Login

Site Newsletter

FREE!

Sign up for the pharmiweb.com newsletter

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

submit a press release
243 Press Releases
previous page1 2 3 4 5 6 7 8 9 next page
DateTitleCompany
22 Apr 13 Alcon announces FDA approval of Simbrinza(TM) Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis
19 Apr 13 New Vertex research shows strong results for potential therapy for most common CF mutation Cystic Fibrosis Trust
18 Apr 13 Sanofi reinforces its presence in Morocco Sanofi
18 Apr 13 Open for Entry - The PM Society Digital Media Awards 2013 PM Society
18 Apr 13 CPhI South East Asia indicates rapid pharma sector growth for the ASEAN CPhI,
Published by
De Facto Communications
18 Apr 13 Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis C Roche
18 Apr 13 New type of bowel cancer discovered Cancer Research UK
17 Apr 13 Mercodia AB announces the signing of exclusive C-PEP3 licensing agreement with SBH Diagnostic Inc Mercodia AB
15 Apr 13 Chinese Group Makes Strategic Investment in Yonkers Biotechnology Company ContraFect,
Published by
AXON
15 Apr 13 CPhI and PharmaEvolution.com to analyze pharma industry in monthly and annual reports CPhI and PharmaEvolution.com ,
Published by
DeFacto
12 Apr 13 Sanofi and PATH announce the Launch of Large-scale Production of Semisynthetic Artemisinin against Malaria Sanofi
12 Apr 13 Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetesâ„¢ Initiative Bristol-Myers Squibb
12 Apr 13 NICE seeks views on draft guidance for non-Hodgkin's lymphoma treatment NICE
12 Apr 13 Draft guidance from NICE says yes to ranibizumab for common eye condition NICE
12 Apr 13 Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval Sanofi Pasteur
12 Apr 13 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole) Merck
12 Apr 13 Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient Abbott
12 Apr 13 Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana® and Zyclara® Actavis, Inc
12 Apr 13 Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress Society for Brain Mapping and Therapeutics (SBMT)
10 Apr 13 Mercodia and Profil Institute Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials Mercodia AB
10 Apr 13 ARIAD PRESENTS NEW PRECLINICAL DATA SHOWING PONATINIB OVERCOMES RESISTANT MUTATIONS IN KIT, AN ONCOGENIC DRIVER OF GASTROINTESTINAL STROMAL TUMORS ARIAD Pharmaceuticals, Inc,
Published by
Biosector 2
08 Apr 13 New PDUFA action date announced by the US FDA for Injectafer® New Drug Application Vifor Pharma ,
Published by
Vifor Pharma
08 Apr 13 Lundbeck announces positive results for Brintellixâ„¢ (vortioxetine) in adult patients with major depression and inadequate response to SSRI or SNRI therapy H. Lundbeck A/S,
Published by
Lundbeck
03 Apr 13 OGT releases new CytoSureâ„¢ microarray for research into haematological and solid cancers Oxford Gene Technology
03 Apr 13 New Study Suggests Point-of-Care Biomarker Plasma NGAL Improves Clinical Diagnosis of AKI in the Emergency Department Alere Inc.
03 Apr 13 Undergraduate studies enter a whole new world with Tecan’s Infinite® M200 PRO Tecan
02 Apr 13 SUNOVION EUROPE ANNOUNCES NEW NAME Sunovion Pharmaceuticals Europe Ltd,
Published by
Munro & Forster
02 Apr 13 Update on Developmental and Clinical Activity ValiRx Plc,
Published by
ValiRx plc
02 Apr 13 Clavis Pharma announces negative outcome of Phase III CLAVELA trial with elacytarabine in patients with acute myeloid leukaemia Clavis Pharma
27 Mar 13 NICE has recently recommended omalizumab (Xolair, Novartis Pharmaceuticals UK) as an option for treating severe, persistent allergic asthma in adults, adolescents and children. The SMi Group ,
Published by
SMi Group Ltd
previous page1 2 3 4 5 6 7 8 9 next page
subscribe in a reader
Advertising
Share | | |

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.